Caricamento...
Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
The clinical success of small-molecule vascular disrupting agents (VDAs) depends on their combination with conventional therapies. Scheduling and sequencing remain key issues in the design of VDA–chemotherapy combination treatments. This study examined the antitumour activity of ZD6126, a microtubul...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360417/ https://ncbi.nlm.nih.gov/pubmed/17848949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603969 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|